ASCO Genitourinary Cancers Symposium
Playback speed
10 seconds
ASCO GU 2022 PROpel Phase III Trial Highlights: Olaparib & Abiraterone vs. Placebo & Abiraterone as 1L Therapy for mCRPC
By
ASCO Genitourinary Cancers Symposium
FEATURING
Fred Saad
By
ASCO Genitourinary Cancers Symposium
FEATURING
Fred Saad
364 views
March 8, 2022
Login to view comments.
Click here to Login
Videos